GlassScriptPhysician profile
Tariq Latif
NPI 1619466208
$843.61
in general payments reported to CMS, 2019-2025
18 companies · $380 in 2025
The $380 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $264 · 2023: $137 · 2024: $62.30 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $198.65 | 2023-2025 | Rybelsus, Ozempic |
| Zealand Pharma US, INC. | $137.24 | 2022 | |
| Amneal Pharmaceuticals LLC | $65.93 | 2022-2023 | Unithroid |
| Lilly USA, LLC | $64.96 | 2023 | Baqsimi, Lyumjev, Mounjaro |
| Sequel Med Tech, LLC | $55.67 | 2025 | Twiist |
| Novartis Pharmaceuticals Corporation | $48.56 | 2025 | |
| Abbvie INC. | $46.51 | 2022 | |
| Merck Sharp & Dohme LLC | $36.90 | 2022 | |
| Medtronic, INC. | $24.76 | 2025 | Minimed 780g |
| Pfizer INC. | $24.04 | 2025 | |
| Xeris Pharmaceuticals, INC. | $23.74 | 2025 | Gvoke Hypopen |
| Insulet Corporation | $22.43 | 2025 | Omnipod |
| Amgen INC. | $19.43 | 2022 | |
| Kyowa Kirin, INC. | $18.00 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.90 | 2024 | Jardiance, Synjardy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $17.20 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $14.26 | 2023 | |
| Beta Bionics, INC. | $7.43 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tariq Latif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.